Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cryopyrin-Associated Periodic Syndromes (CAPS)”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Large-scale testing (Phase 3)Study completedNCT01302860
What this trial is testing

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 17
Not applicableLooking for participantsNCT06544018
What this trial is testing

Circadian Rhythm Deregulation in Patients With CAPS

Who this might be right for
Cryopyrin Associated Periodic SyndromeFamilial Cold UrticariaMuckle-Wells Syndrome+1 more
Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT00465985
What this trial is testing

Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome

Who this might be right for
Muckle Wells Syndrome
Novartis 35
Not applicableLooking for participantsNCT06838143
What this trial is testing

Ilaris NIS in Korea

Who this might be right for
Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00487708
What this trial is testing

Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms

Who this might be right for
NALP3 Mutation
Novartis Pharmaceuticals 34
Not applicableEnded earlyNCT03219918
What this trial is testing

Adenoma Detection Rate in Colonoscopy Performed With EndoRings

Who this might be right for
Colorectal AdenomaColorectal Neoplasms
Zealand University Hospital 97
Testing effectiveness (Phase 2)WithdrawnNCT01211977
What this trial is testing

A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease

Who this might be right for
Muckle Wells SyndromeAutoinflammatoryBehcet's Disease
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not applicableStudy completedNCT02326376
What this trial is testing

Kineret CAPS Post Authorisation Study

Who this might be right for
Cryopyrin-Associated Periodic Syndromes
Swedish Orphan Biovitrum 12
Large-scale testing (Phase 3)Ended earlyNCT00770601
What this trial is testing

Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease

Who this might be right for
NOMIDCINCA Syndrome
Novartis Pharmaceuticals 7
Not applicableNot Yet RecruitingNCT05292768
What this trial is testing

Are Mast Cells Involved in Autoinflammatory Diseases

Who this might be right for
Autoinflammatory DiseaseFMFTRAPS+3 more
Assistance Publique - Hôpitaux de Paris 590
Early research (Phase 1)Study completedNCT04015076
What this trial is testing

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid

Who this might be right for
Healthy
Inflazome UK Ltd 80
Testing effectiveness (Phase 2)Ended earlyNCT00069329
What this trial is testing

Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Nervous System MalformationsArthropathy, NeurogenicUrticaria+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 43
Large-scale testing (Phase 3)Study completedNCT00991146
What this trial is testing

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 19
Not applicableStudy completedNCT04856540
What this trial is testing

Adult Outcomes of Children With CAPS

Who this might be right for
Cryopyrin Associated Periodic Syndrome
University Hospital, Lille 54
Large-scale testing (Phase 3)Study completedNCT00685373
What this trial is testing

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Cryopyrin-Associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle Wells Syndrome+1 more
Novartis 166
Testing effectiveness (Phase 2)Ended earlyNCT02853084
What this trial is testing

HL2351 CAPS Phase II Study

Who this might be right for
Cryopyrin-Associated Periodic Syndromes (CAPS)
Handok Inc. 8
Early research (Phase 1)Study completedNCT04086602
What this trial is testing

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

Who this might be right for
Healthy VolunteersCryopyrin Associated Periodic Syndrome
Inflazome UK Ltd 64
Large-scale testing (Phase 3)Study completedNCT01105507
What this trial is testing

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Novartis Pharmaceuticals 4
Early research (Phase 1)Looking for participantsNCT06974877
What this trial is testing

Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load

Who this might be right for
Cryopyrin-Associated Periodic SyndromesAmyloidosis
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00288704
What this trial is testing

Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

Who this might be right for
Familial Cold Autoinflammatory Syndrome (FCAS)Familial Cold UrticariaMuckle-Wells Syndrome (MWS)+1 more
Regeneron Pharmaceuticals 104
Next Page